OEP Philippines is focused on marketing prescription medicines of a wide range of therapeutic classes, including anti-hypertensives, anti-anginals, anti-infectives and products for the treatment of respiratory disorders such as chronic obstructive pulmonary disease (COPD) and allergic rhinitis. In 2008, the company successfully launched more pipeline extensions in the field of metabolism and anti-infectives to serve the market. The product portfolio comprises active pharmaceutical ingredients (APIs) introduced for the very first time in the Philippines such as doxofylline, ebastine, erdosteine, nicorandil, nebivolol and beclometasone + formoterol fixed dose combination, as well as a number of unique speicalty generic products and combination therof.
Karihome Inc., a subsidiary of Orient Euro Pharma Taiwan is a premier distributor of advanced beauty & health products. Based on an active partnership policy, Karihome concentrates its resources on marketing, importation, distribution, and production of consumer & dermatological products particularly skin care and other consumer healthcare.
OEP works hard to market the best prescription medicines from well-known international pharmaceutical companies and strives to provide the best choice for the medical field and patients.